BioCentury
ARTICLE | Financial News

Replimune ticks up after pricing $100.5M IPO

July 20, 2018 2:48 AM UTC

Replimune Group Inc. (NASDAQ:REPL) gained $0.16 to $15.16 on Friday after it raised $100.5 million through the sale of 6.7 million shares at $15 in an IPO. Underwriters are J.P. Morgan, Leerink and BMO Capital Markets.

The price, which was in the middle of Replimune's proposed range of $14-$16, valued the company at $462.6 million...

BCIQ Company Profiles

Forbion

Replimune Group Inc.